相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic and predictive value of loss of nuclear RAD51 immunoreactivity in resected non-small cell lung cancer patients
Mariam Gachechiladze et al.
LUNG CANCER (2017)
Potential Role of Single Nucleotide Polymorphisms of XRCC1, XRCC3, and RAD51 in Predicting Acute Toxicity in Rectal Cancer Patients Treated With Preoperative Radiochemotherapy
Mattia F. Osti et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2017)
Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein
Alaa Tarig Alshareeda et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Expression Levels of DNA Damage Repair Proteins Are Associated With Overall Survival in Platinum-Treated Advanced Urothelial Carcinoma
Stephanie A. Mullane et al.
CLINICAL GENITOURINARY CANCER (2016)
The Tumor-Associated Variant RAD51 G151D Induces a Hyper-Recombination Phenotype
Carolyn G. Marsden et al.
PLOS GENETICS (2016)
Targeting homologous recombination, new pre-clinical and clinical therapeutic combinations inhibiting RAD51
Ambber Ward et al.
CANCER TREATMENT REVIEWS (2015)
Differences in Expression of Key DNA Damage Repair Genes after Epigenetic-Induced BRCAness Dictate Synthetic Lethality with PARP1 Inhibition
Adrian P. Wiegmans et al.
MOLECULAR CANCER THERAPEUTICS (2015)
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
J. Mateo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The RAD51 135G>C polymorphism is related to the effect of adjuvant therapy in early breast cancer
K. Soderlund Leifler et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)
Rad51 Expression Is a Useful Predictive Factor for the Efficacy of Neoadjuvant Chemoradiotherapy in Squamous Cell Carcinoma of the Esophagus
Tomonori Nakanoko et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Assessing the function of homologous recombination DNA repair in malignant pleural effusion (MPE) samples
M. J. Patterson et al.
BRITISH JOURNAL OF CANCER (2014)
Increased γ-H2AX and Rad51 DNA Repair Biomarker Expression in Human Cell Lines Resistant to the Chemotherapeutic Agents Nitrogen Mustard and Cisplatin
Sheba Adam-Zahir et al.
CHEMOTHERAPY (2014)
Functional Ex Vivo Assay to Select Homologous Recombination-Deficient Breast Tumors for PARP Inhibitor Treatment
Kishan A. T. Naipal et al.
CLINICAL CANCER RESEARCH (2014)
Genetic 135G/C polymorphism of RAD51 gene and risk of cancer: a meta-analysis of 28,956 cases and 28,372 controls
Bei-bei Zhang et al.
FAMILIAL CANCER (2014)
An ex vivo assay of XRT-induced Rad51 foci formation predicts response to PARP-inhibition in ovarian cancer
Monjri M. Shah et al.
GYNECOLOGIC ONCOLOGY (2014)
DNA Double-Strand Break Repair Genes and Oxidative Damage in Brain Metastasis of Breast Cancer
Stephan Woditschka et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
The impact of functional LIG4 polymorphism on platinum-based chemotherapy response and survival in non-small cell lung cancer
You-Hua Jiang et al.
MEDICAL ONCOLOGY (2014)
Relationship between Rad51 G135C and G172T Variants and the Susceptibility to Cancer: A Meta-Analysis Involving 54 Case-Control Studies
Mengmeng Zhao et al.
PLOS ONE (2014)
Immunohistochemical prediction of brain metastases in patients with advanced breast cancer: The role of Rad51
Katarzyna Sosinska-Mielcarek et al.
BREAST (2013)
RAD51 overexpression is a negative prognostic marker for colorectal adenocarcinoma
Pierre Tennstedt et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Detection of Impaired Homologous Recombination Repair in NSCLC Cells and Tissues
Moritz Birkelbach et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Expression and regulation of RAD51 mediate cellular responses to chemotherapeutics
Zhengguan Yang et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Inhibiting homologous recombination for cancer therapy
Sophia B. Chernikova et al.
CANCER BIOLOGY & THERAPY (2012)
RNF8 Regulates Assembly of RAD51 at DNA Double-Strand Breaks in the Absence of BRCA1 and 53BP1
Shinichiro Nakada et al.
CANCER RESEARCH (2012)
Clinicopathological Features of Homologous Recombination-Deficient Epithelial Ovarian Cancers: Sensitivity to PARP Inhibitors, Platinum, and Survival
Asima Mukhopadhyay et al.
CANCER RESEARCH (2012)
The DNA damage response and cancer therapy
Christopher J. Lord et al.
NATURE (2012)
A dual role of BRCA1 in two distinct homologous recombination mediated repair in response to replication arrest
Zhihui Feng et al.
NUCLEIC ACIDS RESEARCH (2012)
Homologous recombination and its regulation
Lumir Krejci et al.
NUCLEIC ACIDS RESEARCH (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Elevated Expression of Rad51 is Correlated With Decreased Survival in Resectable Esophageal Squamous Cell Carcinoma
Yong Li et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
Influence of DNA repair RAD51 gene variants in overall survival of non-small cell lung cancer patients treated with first line chemotherapy
Augusto Nogueira et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
A Marker of Homologous Recombination Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Primary Breast Cancer
Monika Graeser et al.
CLINICAL CANCER RESEARCH (2010)
The BRC Repeats of BRCA2 Modulate the DNA-Binding Selectivity of RAD51
Aura Carreira et al.
CELL (2009)
Overexpression of RAD51 occurs in aggressive prostatic cancer
Anita Mitra et al.
HISTOPATHOLOGY (2009)
RAD51 PROTEIN EXPRESSION AND SURVIVAL IN PATIENTS WITH GLIOBLASTOMA MULTILFORME
James W. Welsh et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Utility of DNA Repair Protein Foci for the Detection of Putative BRCA1 Pathway Defects in Breast Cancer Biopsies
Henning Willers et al.
MOLECULAR CANCER RESEARCH (2009)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The consequences of Rad51 overexpression for normal and tumor cells
Hannah L. Klein
DNA REPAIR (2008)
Use of the Rad51 promoter for targeted anti-cancer therapy
Christopher M. Hine et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
RAD51 up-regulation bypasses BRCA1 function and is a common feature of BRCA1-deficient breast tumors
Richard W. Martin et al.
CANCER RESEARCH (2007)
The BRCA1/BRCA2/Rad51 complex is a prognostic and predictive factor in early breast cancer
Karin Soderlund et al.
RADIOTHERAPY AND ONCOLOGY (2007)
Combined evaluation of Rad51 and ERCC1 expressions for sensitivity to platinum agents in non-small cell lung cancer
Tomoyoshi Takenaka et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation
Jonathan A. F. Hannay et al.
MOLECULAR CANCER THERAPEUTICS (2007)
P53 modulates homologous recombination by transcriptional regulation of the RAD51 gene
C Arias-Lopez et al.
EMBO REPORTS (2006)
Immunohistochemical expression of DNA repair proteins in familial breast cancer differentiate BRCA2-associated tumors
E Honrado et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Rad51 siRNA delivered by HVJ envelope vector enhances the anti-cancer effect of cisplatin
M Ito et al.
JOURNAL OF GENE MEDICINE (2005)
High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients
GB Qiao et al.
BRITISH JOURNAL OF CANCER (2005)
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
J Bartkova et al.
NATURE (2005)
RAD51 localization and activation following DNA damage
M Tarsounas et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2004)
Hallmarks of 'BRCAness' in sporadic cancers
N Turner et al.
NATURE REVIEWS CANCER (2004)
Homologous recombination and cell cycle checkpoints:: Rad51 in tumour progression and therapy resistance
W Henning et al.
TOXICOLOGY (2003)
A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers
E Levy-Lahad et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Rad51 accumulation at sites of DNA damage and in postreplicative chromatin
S Tashiro et al.
JOURNAL OF CELL BIOLOGY (2000)
DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma
H Maacke et al.
ONCOGENE (2000)
分享论文
